Systemic inhibition of myeloid dendritic cells by circulating HLA class I molecules in HIV-1 infection

Retrovirology

Volumn 9, Issue , 2012, Pages

  Huang, Jinghe ^a   Al Mozaini, Maha ^a,b,c   Rogich, Jerome ^a   Carrington, Mary F ^a   Seiss, Katherine ^a   Pereyra, Florencia ^a   Lichterfeld, Mathias ^b   Yu, Xu G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Dendritic cells; HIV 1; HLA; Immunoregulation; Leukocyte immunoglobulin like receptor (LILR)

Indexed keywords

HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; ISOPROTEIN; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DYSREGULATION; IMMUNOMODULATION; MIXED LYMPHOCYTE REACTION; MOLECULAR INTERACTION; MONOCYTE; MYELOID DENDRITIC CELL; PROTEIN DETERMINATION; PROTEIN FUNCTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; BLOOD; DENDRITIC CELL; DRUG EFFECT; GENE EXPRESSION PROFILING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PATHOGENICITY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGEN PRESENTATION; BLOTTING, WESTERN; DENDRITIC CELLS; GENE EXPRESSION PROFILING; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE TOLERANCE;

EID: 84856299818     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-11     Document Type: Article

References (28)

1. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008, 214:231-241. 10.1002/path.2276, 18161758.
2. Schulze Zur Wiesch J, Thomssen A, Hartjen P, Toth I, Lehmann C, Meyer-Olson D, Colberg K, Frerk S, Babikir D, Schmiedel S, et al. Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol 2011, 85:1287-1297. 10.1128/JVI.01758-10, 3020516, 21047964.
3. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS, et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006, 12:1198-1202. 10.1038/nm1482, 16917489.
4. Kaufmann DE, Kavanagh DG, Pereyra F, Zaunders JJ, Mackey EW, Miura T, Palmer S, Brockman M, Rathod A, Piechocka-Trocha A, et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 2007, 8:1246-1254. 10.1038/ni1515, 17906628.
5. Vlad G, Piazza F, Colovai A, Cortesini R, Della Pietra F, Suciu-Foca N, Manavalan JS. Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals. Hum Immunol 2003, 64:483-489. 10.1016/S0198-8859(03)00040-5, 12691698.
6. Huang J, Burke PS, Cung TD, Pereyra F, Toth I, Walker BD, Borges L, Lichterfeld M, Yu XG. Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers. J Virol 2010, 84:9463-9471. 10.1128/JVI.01009-10, 2937602, 20631139.
7. Allison JP, Pellegrino MA, Ferrone S, Callahan GN, Reisfeld RA. Biologic and chemical characterization of HLA antigens in human serum. J Immunol 1977, 118:1004-1009.
8. Singh PB, Brown RE, Roser B. Class I transplantation antigens in solution in body fluids and in the urine. Individuality signals to the environment. J Exp Med 1988, 168:195-211. 10.1084/jem.168.1.195, 2188976, 3294330.
9. Krangel MS. Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 1986, 163:1173-1190. 10.1084/jem.163.5.1173, 2188102, 3701253.
10. Dobbe LM, Stam NJ, Neefjes JJ, Giphart MJ. Biochemical complexity of serum HLA class I molecules. Immunogenetics 1988, 27:203-210. 10.1007/BF00346587, 3276619.
11. Contini P, Ghio M, Merlo A, Brenci S, Filaci G, Indiveri F, Puppo F. Soluble HLA class I/CD8 ligation triggers apoptosis in EBV-specific CD8+ cytotoxic T lymphocytes by Fas/Fas-ligand interaction. Hum Immunol 2000, 61:1347-1351. 10.1016/S0198-8859(00)00212-3, 11163092.
12. Spaggiari GM, Contini P, Dondero A, Carosio R, Puppo F, Indiveri F, Zocchi MR, Poggi A. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood 2002, 100:4098-4107. 10.1182/blood-2002-04-1284, 12393468.
13. Spaggiari GM, Contini P, Carosio R, Arvigo M, Ghio M, Oddone D, Dondero A, Zocchi MR, Puppo F, Indiveri F, Poggi A. Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily. Blood 2002, 99:1706-1714. 10.1182/blood.V99.5.1706, 11861287.
14. Brown D, Trowsdale J, Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004, 64:215-225. 10.1111/j.0001-2815.2004.00290.x, 15304001.
15. Puppo F, Brenci S, Lanza L, Bosco O, Imro MA, Scudeletti M, Indiveri F, Ferrone S. Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression. Hum Immunol 1994, 40:259-266. 10.1016/0198-8859(94)90025-6, 8002375.
16. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 1996, 2:338-342. 10.1038/nm0396-338, 8612235.
17. Lichterfeld M, Kavanagh DG, Williams KL, Moza B, Mui SK, Miura T, Sivamurthy R, Allgaier R, Pereyra F, Trocha A, et al. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J Exp Med 2007, 204:2813-2824. 10.1084/jem.20061865, 2118510, 18025130.
18. Jones DC, Kosmoliaptsis V, Apps R, Lapaque N, Smith I, Kono A, Chang C, Boyle LH, Taylor CJ, Trowsdale J, Allen RL. HLA Class I Allelic Sequence and Conformation Regulate Leukocyte Ig-Like Receptor Binding. J Immunol 2011,
19. Donaghy H, Gazzard B, Gotch F, Patterson S. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 2003, 101:4505-4511. 10.1182/blood-2002-10-3189, 12576311.
20. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, Lebedeva M, DeCamp A, Li D, Grove D, et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009, 83:3719-3733. 10.1128/JVI.01844-08, 2663284, 19176632.
21. Valdez H, Lederman MM. Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev 1997, 187-228.
22. Huang J, Burke P, Yang Y, Seiss K, Beamon J, Cung T, Toth I, Pereyra F, Lichterfeld M, Yu XG. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2. J Virol 2010, 84:10784-10791. 10.1128/JVI.01292-10, 2950595, 20702625.
23. Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, Piazza F, Lederman S, Colonna M, Cortesini R, Dalla-Favera R, Suciu-Foca N. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002, 3:237-243.
24. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 2005, 19:681-693. 10.1096/fj.04-2078rev, 15857883.
25. Carrington M, O'Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med 2003, 54:535-551. 10.1146/annurev.med.54.101601.152346, 12525683.
26. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330:1551-1557. 3235490, 21051598.
27. Huang J, Goedert JJ, Sundberg EJ, Cung TD, Burke PS, Martin MP, Preiss L, Lifson J, Lichterfeld M, Carrington M, Yu XG. HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. J Exp Med 2009, 206:2959-66. 10.1084/jem.20091386, 2806456, 20008523.
28. Tanabe M, Sekimata M, Ferrone S, Takiguchi M. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain. J Immunol 1992, 148:3202-3209.